This is a preview of subscription content, log in via an institution to check access.
Reference
Kondili LA, et al. Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort. Hepatology : 24 Jul 2017. Available from: URL: http://doi.org/10.1002/hep.29399
Rights and permissions
About this article
Cite this article
Universal HCV treatment cost effective in Italy. PharmacoEcon Outcomes News 784, 30 (2017). https://doi.org/10.1007/s40274-017-4241-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4241-z